FindTrial
Sign In

Comparison of short- and long-term outcomes of robotic and laparoscopic surgery for advanced Siewert II/III adenocarcinoma of the esophagogastric junction

Comparison of short- and long-term outcomes of robotic and laparoscopic surgery for advanced Siewert II/III adenocarcinoma of the esophagogastric junction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106248
Enrollment
Unknown
Registered
2025-07-21
Start date
2024-02-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma of the esophagogastric junction

Interventions

Robotic group:N/A
Laparoscopic group:N/A

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Pathological diagnosis of adenocarcinoma; 2.Siewert classification on the basis of preoperative computed tomography (CT), gastroscopy, intraoperative findings and postoperative specimen examination; 3.Postoperative pathological diagnosis with a TNM stage of pT2-4a N0-3bM0; 4. RG or LG; 5.Tumor esophageal invasion <2 cm; 6.Complete TH approach.

Exclusion criteria

Exclusion criteria: 1.Preoperative neoadjuvant chemotherapy, neoadjuvant chemoradiotherapy, targeted therapy, or immunotherapy; 2.Remnant gastric cancer; 3.Emergency surgery; 4.Preoperative endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD).

Design outcomes

Primary

MeasureTime frame
The 5-year overall survival (OS) ;The 5-year disease-free survival (DFS);—

Countries

Chin

Contacts

Public ContactYongliang Zhao

The First Affiliated Hospital of Army Medical University

yongliang1666@126.com+86 136 4760 9675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026